Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Intangibles (2016 - 2021)

Capricor Therapeutics has reported Intangibles over the past 10 years, most recently at $1083.0 for Q1 2021.

  • Quarterly results put Intangibles at $1083.0 for Q1 2021, down 79.99% from a year ago — trailing twelve months through Mar 2021 was $1083.0 (down 79.99% YoY), and the annual figure for FY2020 was $2165.0, down 66.67%.
  • Intangibles for Q1 2021 was $1083.0 at Capricor Therapeutics, down from $2165.0 in the prior quarter.
  • Over the last five years, Intangibles for CAPR hit a ceiling of $130066.0 in Q1 2017 and a floor of $1083.0 in Q1 2021.
  • Median Intangibles over the past 5 years was $38952.0 (2019), compared with a mean of $48107.1.
  • Peak annual rise in Intangibles hit 27.26% in 2017, while the deepest fall reached 92.14% in 2017.
  • Capricor Therapeutics' Intangibles stood at $93048.0 in 2017, then plummeted by 46.51% to $49772.0 in 2018, then tumbled by 86.95% to $6495.0 in 2019, then crashed by 66.67% to $2165.0 in 2020, then tumbled by 49.98% to $1083.0 in 2021.
  • The last three reported values for Intangibles were $1083.0 (Q1 2021), $2165.0 (Q4 2020), and $3248.0 (Q3 2020) per Business Quant data.